Harrow, Inc. Health Care Organization, Revenue (Deprecated 2018-01-31)
Harrow, Inc. (HROW) reported Health Care Organization, Revenue (Deprecated 2018-01-31) of $8.86 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Income Statement › Other Income
us-gaap:HealthCareOrganizationRevenue · last filed 2018-05-15
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $8.86M, a 45.43% increase year-over-year.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $7.27M, a 25.70% increase year-over-year.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.47M, a 33.24% increase year-over-year.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $6.85M, a 39.72% increase year-over-year.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for fiscal 2017 was $26.68M, a 33.91% increase from fiscal 2016.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for fiscal 2016 was $19.93M, a 106.41% increase from fiscal 2015.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for fiscal 2015 was $9.65M, a 484.38% increase from fiscal 2014.
- Harrow, Inc. health care organization, revenue (deprecated 2018-01-31) for fiscal 2014 was $1.65M.
| Period end | Health Care Organization, Revenue (Deprecated 2018-01-31) 3 month | Health Care Organization, Revenue (Deprecated 2018-01-31) 3 month as first filed | Health Care Organization, Revenue (Deprecated 2018-01-31) 6 month | Health Care Organization, Revenue (Deprecated 2018-01-31) 6 month as first filed | Health Care Organization, Revenue (Deprecated 2018-01-31) 9 month | Health Care Organization, Revenue (Deprecated 2018-01-31) 9 month as first filed | Health Care Organization, Revenue (Deprecated 2018-01-31) 12 month | Health Care Organization, Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $8.86M 10-Q · filed 2018-05-15 | $16.13M derived: sum of 2 quarters · filed 2018-05-15 | $22.60M derived: sum of 3 quarters · filed 2018-05-15 | $29.45M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-12-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $13.75M derived: sum of 2 quarters · filed 2018-03-08 | $20.59M derived: sum of 3 quarters · filed 2018-03-08 | $26.68M 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $6.47M 10-Q · filed 2017-11-14 | $13.32M derived: sum of 2 quarters · filed 2017-11-14 | $19.41M 10-Q · filed 2017-11-14 | $25.20M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-06-30 | $6.85M 10-Q · filed 2017-08-10 | $12.94M 10-Q · filed 2017-08-10 | $18.72M derived: sum of 3 quarters · filed 2018-05-15 | $23.58M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2017-03-31 | $6.09M 10-Q · filed 2018-05-15 | $11.88M derived: sum of 2 quarters · filed 2018-05-15 | $16.73M derived: sum of 3 quarters · filed 2018-05-15 | $21.64M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $5.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $10.64M derived: sum of 2 quarters · filed 2018-03-08 | $15.55M derived: sum of 3 quarters · filed 2018-03-08 | $19.93M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $4.86M 10-Q · filed 2017-11-14 | $9.76M derived: sum of 2 quarters · filed 2017-11-14 | $14.14M 10-Q · filed 2017-11-14 | $17.63M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $4.90M 10-Q · filed 2017-08-10 | $9.28M 10-Q · filed 2017-08-10 | $12.78M derived: sum of 3 quarters · filed 2017-08-10 | $15.46M derived: sum of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | $4.38M 10-Q · filed 2017-05-10 | $7.87M derived: sum of 2 quarters · filed 2017-05-10 | $10.56M derived: sum of 3 quarters · filed 2017-05-10 | $12.47M derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $6.17M derived: sum of 2 quarters · filed 2017-03-21 | $8.09M derived: sum of 3 quarters · filed 2017-03-21 | $9.65M 10-K · filed 2017-03-21 | ||||
| 2015-09-30 | $2.68M 10-Q · filed 2016-11-14 | $4.60M derived: sum of 2 quarters · filed 2016-11-14 | $6.16M 10-Q · filed 2016-11-14 | $6.71M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $1.92M 10-Q · filed 2016-08-15 | $3.48M 10-Q · filed 2016-08-15 | $4.03M derived: sum of 3 quarters · filed 2016-08-15 | $4.47M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $1.56M 10-Q · filed 2016-05-12 | $2.11M derived: sum of 2 quarters · filed 2016-05-12 | $2.55M derived: sum of 3 quarters · filed 2016-05-12 | $3.21M derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $987.00K derived: sum of 2 quarters · filed 2016-03-23 | $1.65M derived: sum of 3 quarters · filed 2016-03-23 | $1.65M 10-K · filed 2016-03-23 | $1.65M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | $439.00K 10-Q · filed 2015-11-12 | $439.37K 10-Q · filed 2014-11-12 | $1.10M derived: sum of 2 quarters · filed 2015-11-12 | $1.10M 10-Q · filed 2015-11-12 | $1.10M 10-Q · filed 2014-11-12 | |||
| 2014-06-30 | $664.00K 10-Q · filed 2015-08-12 | $664.37K 10-Q · filed 2014-08-13 | $664.00K 10-Q · filed 2015-08-12 | $664.37K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |